MicroRNA-148a suppresses proliferation and invasion potential of non-small cell lung carcinomas via regulation of STAT3

References

• SiegelRNaishadhamDJemalACancer statistics, 2013CA Cancer J Clin201363113023335087
   PubMed Web of Science ®Google Scholar
• SiegelRNaishadhamDJemalACancer statistics, 2012CA Cancer J Clin201262102922237781
   PubMed Web of Science ®Google Scholar
• HerbstRSHeymachJVLippmanSMLung cancerN Engl J Med2008359131367138018815398
   PubMed Web of Science ®Google Scholar
• ClaassensLvan MeerbeeckJCoensCHealth-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trialsJ Clin Oncol201129152104212021464420
   PubMedGoogle Scholar
• HuZChenXZhaoYSerum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancerJ Clin Oncol201028101721172620194856
   PubMed Web of Science ®Google Scholar
• ShtivelmanEHensingTMolecular pathways and therapeutic targets in lung cancerOncotarget201451392143324722523
   PubMed Web of Science ®Google Scholar
• ScagliottiGVNovelloSAdjuvant therapy in completely resected non-small-cell lung cancerCurr Oncol Rep2003531832512781075
   PubMedGoogle Scholar
• SandlerAGrayRPerryMCPaclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerN Engl J Med2006355242542255017167137
   PubMed Web of Science ®Google Scholar
• SocinskiMASeeking new options for the treatment of small-cell lung cancer. Lung cancer (Amsterdam, Netherlands)Lung Cancer200550Suppl 1S25S26
   PubMedGoogle Scholar
• RanganathanKSivasankarVMicroRNAs – biology and clinical applications. Journal of oral and maxillofacial pathologyJ Oral Maxillofac Pathol201418222923425328304
   PubMedGoogle Scholar
• LiMHFuSBXiaoHSGenome-wide analysis of microRNA and mRNA expression signatures in cancerActa Pharmacol Sin201536101200121126299954
   PubMedGoogle Scholar
• WinterJJungSKellerSGregoryRIDiederichsSMany roads to maturity: microRNA biogenesis pathways and their regulationNat Cell Biol200911322823419255566
   PubMed Web of Science ®Google Scholar
• BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
   PubMed Web of Science ®Google Scholar
• RottiersVNajafi-ShoushtariSHKristoFMicroRNAs in metabolism and metabolic diseasesCold Spring Harb Symp Quant Biol20117622523322156303
   PubMedGoogle Scholar
• ZimmermanALWuSMicroRNAs, cancer and cancer stem cellsCancer Lett20113001101920965651
   PubMed Web of Science ®Google Scholar
• KishikawaTOtsukaMOhnoMYoshikawaTTakataAKoikeKCirculating RNAs as new biomarkers for detecting pancreatic cancerWorld J Gastroenterol201521288527854026229396
   PubMed Web of Science ®Google Scholar
• WangPZhuangLZhangJThe serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasLMol Oncol20137333434523177026
   PubMed Web of Science ®Google Scholar
• WangXChenZMicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activationInt J Mol Med201535383984625604748
   PubMedGoogle Scholar
• SunWMaYChenPWangDMicroRNA-10a silencing reverses cisplatin resistance in the A549/cisplatin human lung cancer cell line via the transforming growth factor-beta/Smad2/STAT3/STAT5 pathwayMol Med Rep20151153854385925586740
   PubMedGoogle Scholar
• XuXZhangYJasperJMiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancerOncotarget2016715203812039426967387
   PubMedGoogle Scholar
• LiJSongYWangYLuoJYuWMicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cellsMol Cell Biochem20133801–227728223670799
   PubMed Web of Science ®Google Scholar
• ZhengBLiangLWangCMicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancerClin Cancer Res201117247574758321994419
   PubMed Web of Science ®Google Scholar
• YuBLvXSuLMiR-148a functions as a tumor suppressor by targeting CCK-BR via inactivating STAT3 and Akt in human gastric cancerPloS One2016118e015896127518872
   PubMed Web of Science ®Google Scholar
• LiYDengXZengXPengXThe role of Mir-148a in cancerJ Cancer20167101233124127390598
   PubMed Web of Science ®Google Scholar
• QiuXZhuHLiuSExpression and prognostic value of microRNA-26a and microRNA-148a in gastric cancerJ Gastroenterol Hepatol Epub2016816
   Google Scholar
• GongLWangCGaoYWangJDecreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasisBiomed Pharmacother201683586327470550
   PubMedGoogle Scholar
• WuYYuJMaYWangFLiuHmiR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinomaOncol Lett201612287187827446362
   PubMedGoogle Scholar
• HuangMXDown-expression of circulating micro ribonucleic acid (miRNA)-148/152 family in plasma samples of non-small cell lung cancer patientsJ Cancer Res Ther201612267167527461630
   PubMedGoogle Scholar
• YangJSLiBJLuHWSerum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screeningTumour Biol20153643035304225501703
   PubMedGoogle Scholar
• JoshiPJeonYJLaganaAMicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLCProc Natl Acad Sci U S A20151128650865526124099
   PubMed Web of Science ®Google Scholar
• KiuHNicholsonSEBiology and significance of the JAK/STAT signalling pathwaysGrowth Factors20123028810622339650
   PubMed Web of Science ®Google Scholar
• HeinrichPCBehrmannIMuller-NewenGSchaperFGraeveLInterleukin-6-type cytokine signalling through the gp130/Jak/STAT pathwayBiochem J1998334Pt 22973149716487
   PubMed Web of Science ®Google Scholar
• YehCMChangLYLinSHEpigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancerSci Rep201663169027528092
   PubMed Web of Science ®Google Scholar
• XiangMKimHHoVTGene expression-based discovery of atovaquone as a STAT3 inhibitor and anti-cancer agentBlood Epub2016816
   Google Scholar
• DuanJYueWYuJEIn vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NFkappaB signaling in pancreatic cancer cellsSci Rep201663167227539371
   PubMed Web of Science ®Google Scholar
• YuYZhaoQWangZLiuXYActivated STAT3 correlates with prognosis of non-small cell lung cancer and indicates new anticancer strategiesCancer Chemother Pharmacol201575591792225735252
   PubMed Web of Science ®Google Scholar
• YouSLiRParkDDisruption of STAT3 by niclosamide reverses radioresistance of human lung cancerMol Cancer Ther201413360661624362463
   PubMed Web of Science ®Google Scholar
• ZhuFDaiCFuYPhysalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signalingOncotarget2016789462947626843613
   PubMedGoogle Scholar